Wealth Enhancement Advisory Services »

Vir Biotechnology shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $63k 11k 5.66
2025-06-30 $87k 16k 5.41
2025-03-31 $78k 12k 6.48

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Alps Etf Tr Smith Core Plus (SMTH)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Msci Intl Moment (IMTM)
Amazon (AMZN)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Schwab Strategic Tr Fundamental Intl (FNDF)
Victory Portfolios Ii Usaa Msci Usa Sm (USVM)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Ishares Tr Msci Usa Min Vol (USMV)
Ishares Tr Us Treas Bd Etf (GOVT)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Vir Biotechnology

Sb Investment Advisers
BlackRock
Arch Venture Corp
Vanguard Group
State Street Corporation
FMR
Dimensional Fund Advisors
OrbiMed Advisors
Geode Capital Management
Morgan Stanley
Standard Life Aberdeen
Goldman Sachs Group
Millennium Management
Renaissance Technologies
Charles Schwab Investment Management

View all funds holding Vir Biotechnology